нэгдүгээр зохиогчоор 4 өгүүлэл, хамтарсан зохиогчоор 12 өгүүлэл хэвлэгдсэн (IF- 1-6.5)
1. Temuujin U, Tserendorj A., TserenOchir EO., Sharav Tumenjargal, Chultemdorj Ch et al. 2019. “The First Isolation and Identification of Canine Parvovirus (CPV) Type 2c Variants during 2016–2018 Genetic Surveillance of Dogs in Mongolia.” Infection, Genetics and Evolution 73 (September): 269–75. IF-2.67
2. Sharav Tumenjargal et al., Detection and molecular characterization of equine infectious anemia virus in Mongolian horses. J Vet Med Sci. 2017 Nov 17;79(11):1884-1888. IF-0.91
3. Yu S, Sharav Tumenjargal, Braley-Mullen H. et al., CD8+ T Cells Induce Thyroid Epithelial Cell Hyperplasia and Fibrosis J Immunol. 2011 Feb 15;186(4):2655-62
4. Fang Y, Sharav Tumenjargal, Braley-Mullen H. et al., Comparison of sensitivity of Th1, Th2, and Th17 cells to Fas-mediated apoptosis . J Leukoc Biol. 2010 Jun;87(6):1019-28.
5. Gross S, Sharav Tumenjargal , Walden P. et al., Immunosuppressive mechanisms in cancer: consequences for the development of therapeutic vaccines. Vaccine. 2009 May 26;27(25-26):3398-400. Epub 2009 Feb 5.
6. Forgber M, Sharav Tumenjargal, Walden P. et al., Proteome-Based Analysis of Serologically Defined Tumor-Associated Antigens in Cutaneous Lymphoma. PLoS One. 2009 Dec 18;4(12):e8376.
7. Sharav Tumenjargal, Wiesmueller KH, Walden P. Mimotope vaccines for cancer immunotherapy. Vaccine. 2007 Apr 20;25(16):3032-7
8. Filter, M., Sharav, Tumenjargal, Walden, P., Wrede, P. et al., A Strategy for the Identification of Canonical and Non-canonical MHC I-binding Epitopes Using an ANN-based Epitope Prediction Algorithm. QSAR & Combinatorial Science vol. 25 issue 4 April 2006. p. 350 - 358
9. Bredenbeck A, Losch FO, Sharav Tumenjargal, Sterry W, Wrede P, Walden P. Identification of noncanonical melanoma-associated T cell epitopes for cancer immunotherapy J Immunol. 2005 Jun 1;174(11):6716-24.
10. Trefzer U, Herberth G, Sharav Tumenjargal, Walden P. et al., Tumour-dendritic hybrid cell vaccination for the treatment of patients with malignant melanoma: Immunological effects and clinical results Vaccine 23(17-18):2367-73
11. Trefzer U, Herberth G, Wohlan K, Milling A, Thiemann M, Sharav Tumenjargal, Sparbier K, Sterry W, Walden P. Vaccination with hybrids of tumor and dendritic cells induces tumor-specific T cell and clinical responses in melanoma stage III and IV patients. Int J Cancer 2004. 110(5): 730-740.
12. Fischer TC, Gellrich S, Muche JM, Sharav Tumenjargal, Audring H, Neitzel H, Walden P, Sterry W, Tonnies H. Analysis of cutaneous T cell lymphoma with comparative genomic hybridization (CGH) reveals a characteristic pattern of chromosomal aberrations: Correlation with the clinical course. J Invest Dermatol 2004. 122: 579-586.
13. Sharav Tumenjargal, Sterry W, Walden P. et al., Anti-tumor immune responses and tumor regression induced with mimotopes of a tumor-associated T cell epitope. Eur J Immunol 2003. 33: 3175-3185.
14. Sharav Tumenjargal, Wiesmuller KH, Walden P. Mimotopes of tumor-associated T-cell epitopes for cancer vaccines determined with combinatorial peptide libraries. Mol Biotechnol 2003. 25: 53-61.
15. Demine R, Sharav Tumenjargal, Walden P. Biochemical determination of natural tumor-associated T-cell epitopes. Mol Biotechnol 2003. 25: 71-78.
16. Linnemann T, Sharav Tumenjargal, Gellrich S, Wiesmuller K, Kaltoft K, Sterry W, Walden P. Mimotopes for tumor-specific T lymphocytes in human cancer determined with combinatorial peptide libraries. Eur J Immunol 2001. 31: 156-165.